| scholarly article | Q13442814 |
| P50 | author | Gideon Koren | Q5559617 |
| P2093 | author name string | Peeters M | |
| Zipursky A | |||
| Jakubovicz D | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| lymphoblastic leukemia | Q18553852 | ||
| P304 | page(s) | 228-232 | |
| P577 | publication date | 1988-03-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Physician compliance and relapse rates of acute lymphoblastic leukemia in children | |
| P478 | volume | 43 |
| Q32173689 | 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia |
| Q47980818 | Adherence to leukemia maintenance therapy: a comparative study among children, adolescents, and adults |
| Q36094702 | Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy |
| Q35653054 | Children, cancer, and nutrition--A dynamic triangle in review |
| Q38700644 | Clinical pharmacology of cancer chemotherapy in children. |
| Q42153311 | Compliance and adherence of patients in the treatment of acute lymphoblastic leukemia |
| Q36153513 | Compliance with a protocol for acute lymphoblastic leukemia in childhood |
| Q43231309 | DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma |
| Q83203008 | Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions |
| Q35626568 | Importance of 6-mercaptopurine dose in lymphoblastic leukaemia |
| Q80853383 | Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia |
| Q34797124 | Maintenance treatment and shared care in lymphoblastic leukaemia |
| Q33625090 | Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis |
| Q27023839 | Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction |
| Q41635870 | Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders |
| Q33418418 | Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity |
| Q91621147 | Prediction of leukocyte counts during paediatric acute lymphoblastic leukaemia maintenance therapy |
| Q35982421 | Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia |
| Q36933578 | Rethinking Adherence: A Proposal for a New Approach to Risk Assessment |
| Q43174427 | The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse |
| Q34798033 | The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia |
Search more.